Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke

Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke - Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049038

Enrollment

50117

Registered

2022-09-30

Start date

2021-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caregivers of patients with schizophrenia, depression, Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Respondents to the NHWS in 2016 and 2018, 18 years of age or older, self-reported caring for adults suffering from schizophrenia, depression, Alzheimer's disease, dementia and stroke. <Selection of non-caregivers> Respondents reported not caring for any adults suffering from any conditions were considered non-caregivers. A 1:1 propensity score matching process will be used to identify a control group of non-caregivers.

Exclusion criteria

Exclusion criteria: - Respondents who did not provide sufficient answers are excluded from the study. - For respondents who participated in both NHWS 2016 and 2018, only the most recent response (NHWS 2018) will be collected and the response from NHWS 2016 will be excluded.

Design outcomes

Primary

Measure	Time frame
Health outcomes: SF-12v2 PCS (Physical component summary) SF-12v2 MCS (Mental component summary) SF-6D index (SF-12v2) EQ-5D-5L Work Productivity and Activity Impairment (WPAI) Healthcare resource utilization (HRU) Patient Health Questionnaire-9 Caregiver reaction assessment (CRA) Costs	—

Countries

Japan

Contacts

Public ContactYoshitsugu Kojima

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

kojimayo@otsuka.jp0367171400

Outcome results